Life Sciences halka açık
[search 0]
Daha fazla
Download the App!
show episodes
 
Artwork
 
The Life Sciences D’n’A podcast is hosted by AI and data analytics experts and pharma industry veterans Nagaraja Srivatsan and Amar Drawid. They explore the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
  continue reading
 
Explore the transition from academia to industry with Voices of Life Sciences. This podcast shares authentic stories from professionals navigating their different life sciences career. Each episode combines testimonials with expert analysis and actionable advice, offering valuable tools to overcome obstacles and build a successful career. Perfect for aspiring talents and anyone passionate about science and innovation! Presented by Biopôle SA.
  continue reading
 
Artwork

1
Being a Life Sciences Leader

Life Sciences Pennsylvania

icon
Unsubscribe
icon
Unsubscribe
Aylık
 
With a bird’s-eye-view of the life sciences industry, Life Sciences Pennsylvania President & CEO, Chris Molineaux, joins Rachael Bushey, Partner and Co-managing Partner of the Philadelphia office of Goodwin Procter to welcome life sciences leaders to give insights into the complex and high-risk world of pharmaceuticals, biotechnology, medical devices, diagnostics and the services that support them. Here we learn what it means to be a life sciences leader.
  continue reading
 
Artwork
 
Life Sciences 360 is an interview show that educates anyone on challenges, trends, and insights in the life-sciences industry. Hosted by Harsh Thakkar, a life-sciences industry veteran and CEO and co-founder of Qualtivate, the show features subject-matter experts, business leaders, and key life-science partners contributing to bringing new therapies to patients worldwide. Harsh is passionate about advancements in life sciences and tech and is always eager to learn from his guests— making the ...
  continue reading
 
The Life Sciences GenAI Exchange is a ground-breaking new podcast that brings together influential stakeholders from Life Sciences regulators, investors, practitioners and technologists, to exchange ideas and discuss practical experiences around the use of GenAI. Each podcast features top minds from across the Life Sciences industry sharing their insights and experiences in a lively session designed to stimulate ideas and discussion and help identify positive and actionable ways to embrace G ...
  continue reading
 
Leading Minds podcast by Life Sciences Voice delves deep inside the minds of the top life sciences executives, including pharmaceuticals, biotech, medical devices, consumer health, animal health, and leaders from related industries. In every episode, we meet a leader who has made a lasting impact in the life sciences industry and continues to drive the industry forward. We go beyond the name and the title to unravel their personality, their beliefs, their mission, and most importantly, to un ...
  continue reading
 
Students and scholars in life sciences need to use many skills to survive and excel during scientific training, which involves listening, reading, writing, and speaking. But I have seen many of them struggle in understanding and learning those skills. I am a professor in the U.S., a tenured faculty member with MD, PhD degrees. I will guide you through the skills, so that you will learn and improve successfully in your professional life. Please visit my website for more information (https://s ...
  continue reading
 
Artwork

1
Life Sciences Weekly

Matthew Davison

icon
Unsubscribe
icon
Unsubscribe
Haftalık
 
Life Sciences Weekly is your go-to podcast for a fast, focused, and insightful snapshot of the week in medtech, biotech, and pharma. Each Saturday, we break down the latest market trends, FDA approvals and submissions, regulatory shifts, enforcement actions, startup funding, and M&A activity—all in under 20 minutes. Whether you're an industry insider, investor, or innovator, Life Sciences Weekly keeps you ahead of the curve with expert context and a spotlight on the stories shaping the futur ...
  continue reading
 
Join Štěpán Hýsek as he hosts interviews about exciting research projects across various life sciences fields. 'SHowcase for life sciences' is a place where researchers themselves present findings of their cutting-edge research.
  continue reading
 
What are the biggest challenges and opportunities facing the life sciences sector? How can we overcome these challenges while unlocking the opportunities? Join host Stuart Lowe and a roster of expert guests as they unpack the past, present and future of cell and gene therapy.
  continue reading
 
BDO’s Health & Life Sciences Rx Podcast, hosted by The BDO Center for Healthcare Excellence & Innovation and the Life Sciences practice, seeks to provide insights into the trends disrupting healthcare and how companies can adapt and evolve in an ever-changing business landscape.
  continue reading
 
In this limited podcast series, we’ve brought together a series of conversations with experts from medical science to finance to help demystify investing in biotech, medtech and digital health (also known as the life sciences). This podcast has been brought to you by Life Sciences WA (Western Australia’s Life Sciences Industry Association) in collaboration with Talking HealthTech. It has been possible with funding support from the West Australian government through the New Industries Fund an ...
  continue reading
 
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
  continue reading
 
Artwork

1
Life Sciences in Queensland Podcast

Life Sciences Queensland

icon
Unsubscribe
icon
Unsubscribe
Aylık
 
Join us on this podcast series as we meet the icons of the biotechnology industry, exploring the current state of innovation in Queensland and what the future holds for our best and brightest. Hosted by Anthony Frangi, each episode will feature a new guest sharing their unique angle on the capabilities of the industry in Queensland.
  continue reading
 
Artwork
 
The Cambridge Centre for Law, Medicine and Life Sciences (LML), led by Dr Kathleen Liddell (Director) and Dr Jeffrey Skopek (Deputy Director), advances research and teaching on legal and ethical challenges at the forefront of medicine and the life sciences. Rapid and prolific scientific advances, alongside changing attitudes towards health, medical care, family structures and related issues, pose some of the most difficult research questions of our era. These include questions about the adeq ...
  continue reading
 
Artwork

1
Image Movie Bachelor und Master in Life Sciences | Video

FHNW | HSL | Hochschule für Life Sciences-HSL

icon
Unsubscribe
icon
Unsubscribe
Günlük+
 
Life Sciences tönen nicht nur spannend, sondern sind es auch! Wir messen uns in Lehre und Forschung an internationalen Qualitätsstandards und fördern Transdisziplinarität sowie die Kooperation mit Netzwerken und vielfältigen Partnern. Unser Ziel ist es, den faszinierenden Life Sciences-Wissenschaften marktwirtschaftliche Anwendungen zu geben und gemeinsam mit Forschungspartnern ein international unverwechselbares Hochschulprofil zu etablieren. Im Zentrum unserer Aus- und Weiterbildung steht ...
  continue reading
 
Join Nancy Donohoo’s bi-weekly podcast, Talk at the Top, and get to know the key influencers in life sciences and healthcare who are positively impacting patients, providers, consumers and the industry itself! Nancy’s guests include groundbreakers and executives from across the healthcare spectrum: CEOs, physician executives, medical affairs and scientific leaders, venture capital and private equity investors, academics and entrepreneurs. This is your front row ticket to discussions on innov ...
  continue reading
 
Loading …
show series
 
Fostering equality and opportunity for ourselves and for others starts with action. This episode explores how mentors in senior roles can actively support researchers, promote inclusion and help shape a culture of diversity in the life sciences. By receiving support themselves, mentors are better equipped to embrace inclusive practices as they grow…
  continue reading
 
Life Sciences Weekly Podcast - Episode 3 Recorded: May 17, 2025 In Episode 3 of Life Sciences Weekly, host Matt Davison unpacks a pivotal week for the industry, marked by policy shifts, regulatory actions, and a surge in funding. The show opens with a market recap, highlighting renewed financial strength in the U.S. life sciences sector as venture …
  continue reading
 
Kannan Natarajan, senior vice president at Pfizer, discusses the potential of generative AI to streamline pharmaceutical documentation processes and improve efficiency, what he’s learned about implementing AI solutions, and the cultural challenges of adopting new technologies.Levine Media Group tarafından oluşturuldu
  continue reading
 
In this episode of the Life Sciences Gen I Exchange podcast, host Agnes Cwienczek from ArisGlobal discusses the impact of AI on regulatory affairs with Preeya Beczek, a regulatory affairs and compliance expert. They explore the use of AI in regulatory impact assessments, emphasizing the importance of speeding up the process, ensuring compliance, an…
  continue reading
 
Solving the “Undruggable” Disease Problem with Goldilocks Molecules In this episode, Christian Schafmeister, Founder and President of Third Law Molecular, reveals a new class of therapeutics designed to target what most consider “undruggable” diseases—conditions like Alzheimer’s, certain cancers, and rare genetic disorders. Christian explains the s…
  continue reading
 
In this episode of Leading Minds, host Jasmeet Sawhney sits down with Johanna Rossell, SVP and GM Rare Disease at Sumitomo Pharma America, Inc., to explore the evolving landscape of biotech and rare disease treatment. They discuss the critical need for collaboration across the entire healthcare ecosystem—including the FDA, healthcare providers, and…
  continue reading
 
An episode with Tracy Ring, Accenture’s Chief Data Officer and Global Generative AI Lead for Life Sciences explores how advanced AI, cognitive digital brains, and agentic systems are transforming business efficiency, trust, and customer interactions.Accenture tarafından oluşturuldu
  continue reading
 
Let’s talk about an excellent abstract that I read this week. It was so well written, and I was so excited to read it that I wanted to talk about it with you today. The beauty of it is that the first 3 structural components guide us through the authors’ intention and question very clearly. But there was also a little twist to the structure: we will…
  continue reading
 
Tune in and learn about the $660 million public offering Madrigal Pharmaceuticals received to deliver novel therapeutics for nonalcoholic steatohepatitis (NASH). Hear from Bill Sibold as he shares his experience leading one of the year's most significant biotech fundraisings, the preparations and strategies behind the raise and how this milestone p…
  continue reading
 
Life Sciences Weekly Podcast – Episode 2 Recorded: May 10, 2025 This week on Life Sciences Weekly, host Matt Davison breaks down a whirlwind of developments shaping the biotech, pharma, and medtech landscape. Tune in for a market recap as volatility rocks the sector, with biotech stocks tumbling after Dr. Vinay Prasad is named the new head of the F…
  continue reading
 
A PhD opens countless career paths beyond academia. This episode showcases diverse professional journeys – from science communication to entrepreneurship – and highlights resources that are useful throughout this transition, such as the Chômage system and the BNF national qualification programme.Biopôle SA tarafından oluşturuldu
  continue reading
 
Life Sciences Weekly delivers a fast-paced, insightful roundup of the latest trends, deals, and regulatory news shaping the global life sciences and medical device industries. In this inaugural episode, recorded May 3, 2025, we break down the week’s market movers, highlighting gains in biotech and medtech stocks and renewed investor confidence. Div…
  continue reading
 
Why Startups Fail (Hint: It’s Not the Innovation) In this episode, Carlo Odicino, CEO and Founder at One TEAM Partners, shares the real reasons why most early-stage life sciences companies struggle to survive—and it has nothing to do with bad science. Learn the hidden pitfalls of scaling too fast, confusing innovation with execution, and chasing to…
  continue reading
 
Vinod Das, Pharma R&D, Drug Innovation & AI Scouting for Bayer; sits down with Nagaraja Srivatsan to discuss the integration of generative AI in drug discovery and clinical development. He discusses the journey of AI adoption, the importance of prompt engineering, and the complexities of implementation.…
  continue reading
 
The Hidden Math Behind Drug Pricing: Why Patients Pay More Than They Should In this episode, Michael Grosberg, VP of Product Management at Model N, breaks down the complex drug pricing ecosystem—revealing how rebates, PBMs, and outdated pricing models shape what patients actually pay. You’ll learn how Pharmacy Benefit Managers (PBMs) really operate…
  continue reading
 
My students selected a paper to read in a journal club. The abstract (and the rest of the paper) was not written well. The abstract gave us two precious lessons. Lesson 1: Good structural organization will help the readers understand the content. Lesson 2: Abstracts of peer-reviewed papers can be disorganized. I hope you learn them in this episode,…
  continue reading
 
Early Commercialization Strategies That Actually Work (Especially for Startups!) In this episode, John Harlow, Chief Commercial Officer at Melinta Therapeutics, shares real-world strategies for how lean pharma startups can win the commercialization game—without Big Pharma budgets. Discover how small companies can pivot fast, creatively optimize dis…
  continue reading
 
Vijayalakshmi Ramshankar, professor and head of the Department of Cancer Biology and Molecular Diagnostics at Cancer Institute (WIA) sits down with Nagaraja Srivatsan to discuss the cancer research landscape in India, the work she is doing to leverage AI to improve diagnosis and outcomes, and the future of AI in oncology…
  continue reading
 
Mental health is often neglected in academia, yet maintaining work–life balance is key to a healthy life. This episode explores the unique challenges faced by PhD students and young researchers, and how setting healthy boundaries can protect well-being, foster self-confidence and help them recognise their achievements.…
  continue reading
 
We have reached 50 episodes! Thank you for listening. Today, we will briefly talk about how I have kept sustainable podcasting so far. The most important thing may be that I have set my goal simple and single: It is to create high-quality content for you. That’s it. Here are links to two sources of podcast statistics that I mentioned in the episode…
  continue reading
 
Healthcare AI adoption is transforming the way we address risk, confidentiality, and patient care. In this episode, RJ Kedziora, co-founder of Estenda Solutions talks about the practical steps to safely integrate AI in clinical workflows. Learn how to manage data privacy, mitigate algorithmic bias, and keep a human in the loop to prevent misdiagnos…
  continue reading
 
In this episode of Leading Minds, host Jasmeet Sawhney sits down with Nuray Yurt, the Head of Integrated Research and Forecasting at Merck and PMSA President, to discuss the evolving role of AI and analytics in the pharmaceutical industry. Nuray shares her insights on how Merck is leveraging AI to drive innovation in analytical processes, including…
  continue reading
 
We will talk about the second of the two, well-crafted loops of logic, in the Abstract of a paper written by the Nobel Prize Laureates. Not all abstracts have this second loop. But when it is present, it gives a better overview of the impact of the presented work. We can find one of the best examples in our Abstract. We are reading the paper writte…
  continue reading
 
Manoranjan Das, director of global drug development IT for Bristol Myers Squibb, sits down with Nagaraja Srivatsan to discuss his work to implement AI in clinical development, the importance of change management, and the lessons learned from various AI projects he’s led.Levine Media Group tarafından oluşturuldu
  continue reading
 
Drug serialization is at the heart of modern pharmaceutical supply chain security. In this episode Michael Rowe, Senior Director of DSCSA and Serialization Services at TwoLabs, talks about the critical role of drug serialization and DSCSA compliance in safeguarding the pharmaceutical supply chain. Michael explains how unique serial numbers, standar…
  continue reading
 
Join us as Senator Robinson discusses his key role in passing SB954 - which provides Pennsylvanians better access to personalized treatments following a diagnosis of cancer and other specific diseases through biomarker testing and precision medicine. Learn about Senator Robinson's journey as the bill's prime sponsor, the collaborative efforts to ge…
  continue reading
 
Transitioning from academia to industry after a PhD isn’t always straightforward. This episode highlights the importance of ‘soft skills’ and offers insights on how to name, identify and leverage them. Choosing industry is not a backup plan or a failure – it’s about finding your path to fulfilment, whatever direction you take.…
  continue reading
 
Professor Kimberly D. Krawiec from the University of Virginia School of Law explores "repugnant transactions and taboo trades" — markets that are morally contested and sometimes even prohibited, such as sex work, commercial surrogacy, and the sale of organs, eggs, and sperm. She asks how we, as a society, decide what is up for sale and what is off-…
  continue reading
 
I can visualize two well-crafted loops of logic, in the Abstract of a paper written by the Nobel Prize Laureates. Can you? We will talk about one of them in today’s episode. Such a loop, together with a linear progression, highlights the authors’ clear and logical thought process. We are reading the paper written by the Laureates, Dr. Katalin Karik…
  continue reading
 
Equitable healthcare is the key to bridging health gaps and creating better patient outcomes. In this episode, Amy West, Principal, Advisory Services at HitLab, share her insights on how technology, digital health, and data can reshape access to care—especially for underserved communities. Learn how addressing social determinants, using remote pati…
  continue reading
 
Tune in to this episode with Representative Mullins, recipient of the 2024 State Official of the Year Award, and learn about his pivotal role in passing HB 1754 - which requires all state-regulated health plans to cover comprehensive biomarker testing. Hear about the personal motivation Representative Mullins had to be the prime sponsor of this bil…
  continue reading
 
Let's analyze a single sentence in the Abstract of an impressive paper. It is the paper that led to the 2023 Nobel Prize in Physiology or Medicine. This is the paper that we call the milestone article 1 (Please see below for details). We will analyze the second sentence. Why is this sentence important? We will discuss four of my approaches to see t…
  continue reading
 
Aman Thukral, director of Clinical Systems And Digital Operations at AbbVie, sits down with Nagaraja Srivatsan to discuss the evolving landscape of clinical trials with the integration of AI, why change management is essential for successful implementation, and the need for a long-term investment approach in AI initiatives.…
  continue reading
 
Have you ever wondered if AI could help doctors find cancer faster and more accurately? In this episode, we explore OmniScreen, an AI-powered biomarker tool that is revolutionizing cancer diagnostics. Joe Oakley, a pathologist and expert in digital pathology, explains how OmniScreen was trained on 3 million digital slides to detect cancer biomarker…
  continue reading
 
Ben Doranz, recipient of the 2024 Frank Baldino Bioscience CEO of the Year Award, joins Chris and Rachael this episode to discuss how he led his team through a transformative year in 2024. Under Ben's leadership, Integral Molecular secured an $8 million contract from NIAID to combat emerging viruses, as well as $2.7 million award to advance the Mem…
  continue reading
 
This episode features Adrian (Ad) Rawcliffe, CEO, Adaptimmune, recipient of the Life Sciences PA 2024 Patient Impact Award. Ad shares the story behind TECELRA - the first FDA approved engineered cell therapy for a solid tumor. Learn about the journey leading up to this groundbreaking approval, the challenges of bringing a cell therapy to market and…
  continue reading
 
Today, we will analyze the Abstract of an impressive paper. It is the paper that led to the 2023 Nobel Prize in Physiology or Medicine. This is the paper that we call the milestone article 1. We will have two essential pre-analysis sub-steps, and then we will analyze each sentence. During this analysis, we will read each sentence of the Abstract, e…
  continue reading
 
Tobias Guennel, senior vice president of product innovation and co-founder of QuartzBio, joins Nagaraja Srivatsan to discuss his insights on leveraging AI and advanced analytics to improve clinical trial efficiency, the integration of AI in precision medicine, and the use of AI agents to automate clinical trial operations.…
  continue reading
 
This episode features Fred Vogt, Interim CEO at Iovance Biotherapeutics, recipient of the 2024 Patient Impact Award. In this episode, Fred shares the journey behind AMTAGVI - the first FDA approved tumor infiltrating lymphocyte (TIL) therapy. Learn about the clinical trial process, how they brought this groundbreaking treatment to market, the impac…
  continue reading
 
Have you ever wondered why marketing in the life sciences industry is so different from traditional marketing? In this episode, we dive deep into the power of science marketing, the impact of brand storytelling, and how companies can successfully position their products in a competitive market. From publishing content to collaboration with industry…
  continue reading
 
Host: · Emmanuel “Manny” Belabe Global Head, Operational Excellence at ArisGlobal Guest: Michelle Bridenbaker, RN, BSN, MS, MBA COO of Unbiased Science, VP of MILE (Medical Information Leaders in Europe) Episode Overview: AI is revolutionizing healthcare by enhancing patient safety, streamlining medical communications, and driving improved health o…
  continue reading
 
This episode features Rob Albert, CEO of B. Braun of America, the organization receiving the 2024 Patient Impact Award. Hear from Rob and discover how B. Braun took decisive action during Hurricanes Helene and Milton to secure the supply of critical I.V. fluids to hospitals affected by these disasters. Learn how they collaborated with government ag…
  continue reading
 
Have you ever wondered why so many new drugs fail even after years of research and billions in investment? In this episode, we dive deep into the challenges of drug commercialization, the role of AI in pharma, and the biggest mistakes companies make before going to market. Our guest, Dan Cummings, is a leading expert in go-to-market strategy, havin…
  continue reading
 
Today, we will take a significant step towards understanding the 2023 Nobel Prize in Physiology or Medicine. We will read the Abstract of the Laureates’ most important paper that led to the Nobel Prize. This is the paper that we call the milestone article 1. We will have two essential pre-reading sub-steps, and then we will conduct the initial read…
  continue reading
 
Have you ever wondered why so many clinical trials fail before reaching the market? In this episode, we dive deep into the hidden challenges of clinical trials with Rob Freishtat, President and Co-Founder of Uncommon Cures and a professor at George Washington University School of Medicine and Health Sciences. Rob shares insider knowledge on why ove…
  continue reading
 
Adele Oliva, recipient of the 2025 Hubert J.P. Schoemaker Leadership Award joins Chris and Rachael to discuss her impact on the life sciences industry in PA supporting the growth of commercial stage healthcare companies. In this episode, hear how her career path ultimately led to finding a gap in the ecosystem and later found 1315 Capital. Learn ab…
  continue reading
 
In this episode, Stuart explores the adoption of generative AI in the pharmaceutical industry, with a special focus on cell and gene therapy. While the application of AI for drug discovery has been well documented and a source of considerable investment for the pharmaceutical sector, we are only just starting to see its impact for therapy developer…
  continue reading
 
Loading …

Hızlı referans rehberi

Keşfederken bu şovu dinleyin
Çal